Displaying 37 - 48 of 101
General Hepatology
5

Takeda: A tale of two specialties in AATD: An interactive discussion of case studies - EASL Congress 2024

View
General Hepatology
5

Takeda: A tale of two specialties in AATD: An interactive discussion of case studies - EASL Congress 2024

View
General Hepatology
5

Takeda: A tale of two specialties in AATD: An interactive discussion of case studies - EASL Congress 2024

View
General Hepatology
5

Takeda: A tale of two specialties in AATD: An interactive discussion of case studies - EASL Congress 2024

View
Cirrhosis & Complications
4

Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024

View
Cirrhosis & Complications
4

Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024

View
Cirrhosis & Complications
4

Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024

View
Cirrhosis & Complications
4

Grifols: Long term albumin to manage disease progression: latest evidence and upcoming results - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
3

Mirum: Meet the Experts in Cholestatic Liver Disease - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
3

Mirum: Meet the Experts in Cholestatic Liver Disease - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
3

Mirum: Meet the Experts in Cholestatic Liver Disease - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
6

Mirum: PSC and IBAT Inhibitors: Can We Apply Our Paediatric Experience in Adult Hepatology? - EASL Congress 2024

View
Displaying 37 - 48 of 101